U.S. Pharmacist Opinions Regarding the Rescheduling of Hydrocodone Combination Products: A Pilot Study

U.S. Pharmacist Opinions Regarding the Rescheduling of Hydrocodone Combination Products: A Pilot Study

In October 2014, the Drug Enforcement Administration in the U.S. reclassified hydrocodone combination products (HCPs) from Schedule III to Schedule II, initiating one of the most significant and controversial regulatory changes for opioids in recent national history. The aim of the present study was...

Full description

Bibliographic Details
Main Authors: Jordan R. Covvey, Andrea R. Pfalzgraf, Peter P. Cohron
Format: Article
Language:English
Published: MDPI AG 2015-08-01
Series:Pharmacy
Subjects:
opioids
regulation
Drug Enforcement Administration
controlled substance
Online Access:http://www.mdpi.com/2226-4787/3/3/129

Internet

http://www.mdpi.com/2226-4787/3/3/129

Similar Items